Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Music and hearing]

J Frei

    Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
    |March 24, 1987
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

    Nature communications·2024
    Same author

    [Orbital MALT lymphomas: clinicopathological correlation].

    Klinische Monatsblatter fur Augenheilkunde·2006
    Same author

    [A new MR criterion in the diagnosis of capillary telangiectasis of the brain stem].

    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2004
    Same author

    [Localized argyrosis 58 years after strabismus operation--an ophthalmological rarity].

    Klinische Monatsblatter fur Augenheilkunde·2001
    Same author

    New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis.

    Journal of medicinal chemistry·2000
    Same author

    PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

    Cancer research·2000